(-)Nicotine inhibits the activations of phospholipases A2 and D by amyloid β peptide

Brain Research

Volumn 800, Issue 2, 1998, Pages 275-281

  Singh, Indrapal N ^a   Sorrentino, Guiseppi ^b   Sitar, Daniel S ^a   Kanfer, Julian N ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Alzheimer's; Amyloid beta peptide; Nicotine; Phospholipase A2; Phospholipase D

Indexed keywords

AMYLOID BETA PROTEIN; CHOLINERGIC RECEPTOR STIMULATING AGENT; COTININE; HEXAMETHONIUM; KAINIC ACID; NICOTINE; PHOSPHOLIPASE A2; PHOSPHOLIPASE D; QUISQUALIC ACID; TUBOCURARINE CHLORIDE;

ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; NEUROPROTECTION; PRIORITY JOURNAL; RECEPTOR OCCUPANCY;

ACETOPHENONES; AMYLOID BETA-PROTEIN; ARACHIDONIC ACIDS; ARISTOLOCHIC ACIDS; BRAIN; BRAIN CHEMISTRY; CELLS, CULTURED; COTININE; ENZYME ACTIVATION; ENZYME INHIBITORS; EXCITATORY AMINO ACID AGONISTS; HEXAMETHONIUM; KAINIC ACID; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; PHENANTHRENES; PHOSPHOLIPASE C; PHOSPHOLIPASE D; PHOSPHOLIPASES A; QUISQUALIC ACID; TUBOCURARINE;

EID: 17544404378     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00532-0     Document Type: Article

References (44)

1. Abood L.G., Lowry K., Tometoko A., Booth S. Electrophysiolgical, behavioral, and chemical evidence for a noncholinergic, stereospecific site for nicotine in rat brain. J. Neurosci. Res. 3:1978;327-333.
2. Akaike A., Tamura Y., Yokota T., Shimohama S., Kimura J. Nicotine induced protection of cultured cortical neurons against NMDA receptor-mediated glutamate neurotoxicity. Brain Res. 644:1994;181-187.
3. Aoshiba K., Nagai A., Yousui S., Kono K. Nicotine prolongs neutrophil survival by suppressing apoptosis. J. Lab. Clin. Med. 127:1996;186-194.
4. Barbour B., Szatkowski M., Ingledaw N., Atwell D. Arachidonic acid induces a prolonged inhibition of glutamate uptake into glial cells. Nature. 342:1989;918-920.
5. 4 25-35, mimics the function of substance P on modulation of nicotine-evoked secretion and desensitization in cultured bovine adrenal chromaffin cells. J. Neurochem. 60:1993;1163-1166.
6. Ethimiopoulas S., Vasselacopoulou D., Ripellino J.A., Tezapsides N., Robakis N. The cholinergic agonists stimulate secretion of full length amyloid precursor protein in neuroendocine cells. Proc. Natl. Acad. Sci. 93:1996;8046-8050.
7. A. Goldstein, Biostatistics: An introductory text. MacMillan, New York, 1964, pp. 154-161.
8. Muraki T. Developmental changes in response of rat isolated duodenum to nicotine. Eur. J. Pharmacol. 251:1994;75-81.
9. Kihara T., Shimohama S., Sawnda H., Kimura J., Kume T., Kochiyama H., Maeda T., Akaike A. Nicotinic receptor stimulation protects neurons against β-amyloid toxicity. Ann. Neurol. 42:1997;159-163.
10. Klus H., Kuhn H. A study of the optical activity of smoke nicotines. Fachliche Mitt Oester. Tabakregie. 17:1997;331-336.
11. Lee P.N. Smoking and Alzheimer's disease: a review of the epidemiological evidence. Neuroepidemiology. 13:1994;131-144.
12. Lowry O.H., Rosebrough N., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
13. Marin P., Hamon B., Glowinski J., Premont J. Nicotine-induced inhibition of neuronal phospholipase A2. J. Pharmacol. Exp. Ther. 280:1997;1277-1283.
14. Marin P., Maus M., Desaghers S., Glowinski J., Premont J. Nicotine protects cultured striatal neurons against NMDA receptor-mediated neurotoxicity. Neuroreport. 5:1994;1977-1980.
15. Maurice T., Lockhart B.P., Privat A. Amnesia induced in mice by centrally administered beta-amyloid peptides involve cholinergic dysfunction. Brain Res. 706:1996;181-193.
16. McGeer P.L., Rogers J. Anti-inflammatory drugs as a therapeutic approach to Alzheimer's disease. Neurology. 42:1992;447-449.
17. McGehee D.S., Role L.W. Physiological diversity of nicotine acetylcholine receptors expressed by vertebrate neurons. Annu. Rev. Physiol. 57:1995;521-546.
18. Meltzer L.T., Rosencrans J.A. Nicotine and arecoline as discriminative stimuli: involvement of a non-cholinertic mechanism for nicotine. Pharmacol. Biochem. Behav. 29:1988;587-593.
19. Messing R.O., Stevens A.M., Kiyasu E., Sneade A.B. Nicotinic and muscarinic agonists stimulate rapid protein kinase C translocation in PC12 cells. J. Neurosci. 9:1989;507-512.
20. Monteggia L.M., Arneric A.P., Giordono T. Nicotine effects on the regulation of amyloid precursor protein splicing, neurotrophin and glucose transporter RNA levels in aged rats. Int. J. Dev. Neurosci. 12:1994;133-141.
21. Nwosu C.G., Godin C.S., Houdi A.A., Damani O.A., Crooks P.A. Enantioselective metabolism during continuous administration of S(-)- and R(+)-nicotine isomers to guinea-pigs. J. Pharm. Pharmacol. 40:1988;862-869.
22. J.W. Pettegrew, R.J. McClure, J.N. Kanfer, R.P. Mason, K. Panchalingham, W.E. Klunk, The role of membranes and energetics in Alzheimer's disease. in: R.D. Terry, R. Katzman, K. Beck (Eds.) Alzheimer's Disease, Raven Press, NY, 1994, pp. 369-386.
23. Rowell P.P., Yi M. Dose-response relationship for nicotine-induced up regulation of rat brain nicotinic receptors. J. Neurochem. 68:1997;1982-1989.
24. Salomon A.R., Macinowski K.J., Friedland R.P., Zagorski M.G. Nicotine inhibits amyloid formation by the beta-peptide. Biochemistry. 35:1996;13568-13578.
25. Sargent P.B. The diversity of neuronal nicotinic acetylcholine receptors. Annu. Rev. Neurosci. 16:1993;403-443.
26. Selkoe D.S. Alzheimer's disease: a critical role for amyloid. J. Neuropathol. Exp. Neurol. 53:1994;438-447.
27. Semba J., Miyoshi R., Kito S. Nicotine protects against the dexamethasone potentiation of kainic acid-induced neurotoxicity in cultured hippocampal neurons. Brain Res. 735:1996;335-338.
28. 3H ]nicotine to mouse brain J. Recept. Res. 2:1981;1-9.
29. 2 in LA-N-2 cells. Alzheimer's Res. 2:1996;121-128.
30. Singh I.N., Sorrentino G., Kanfer J.N. Amyloid β protein (25-35) stimulation of phospholipase C in LA-N-2 cells. J. Neurochem. 69:1997;252-258.
31. Singh I.N., Sorrentino G., McCartney D.G., Massarelli R., Kanfer J.N. Enzymatic activities during differentiation of the human neuroblastoma cells, LA-N-1 and LA-N-2. J. Neurosci. Res. 25:1990;476-485.
32. 2 and D of LA-N-2 cells. Neurosci. Lett. 222:1997;5-8.
33. Singh I.N., McCartney D.G., Kanfer J.N. Amyloid beta protein (25-35) stimulation of phospholipases A, C and D activities of LA-N-2 cells. FEBS Lett. 365:1995;125-128.
34. Singh I.N., Sato K., Takashima A., Kanfer J.N. Activation of LA-N-2 cell phospholipases by single alanine substitution analogs of amyloid β peptide (25-35). FEBS Lett. 405:1997;65-67.
35. Singh I.N., Massarelli R., Kanfer J.N. Activation of phospholipases D and A by amphiphilic cations of cultured LA-N-2 cells is G-protein and protein kinase C-independent. J. Lipid Mediators Cell Signal. 7:1993;85-96.
36. I.N. Singh, G. Sorrentino, J.N. Kanfer, Activation of phospholipase D by amyloid β protein in LA-N-2 cells, Neurochem. Res., in press.
37. Sorrentino G., Singh I.N., Massarelli R., Kanfer J.N. Stimulation of phospholipase C activity by norepinephrine, t-ACPD and bombesin in LA-N-2 cells. Eur. J. Pharmacol. 308:1996;81-86.
38. 2+ influx in PC 12 h cells in culture. Neurosci. Lett. 173:1994;147-150.
39. Tuominen R.K., McMillan M.K., Ye H., Stachowiak M.K., Hudson P.M., Hong J.S. Long-term activation of protein kinase C by nicotine in bovine adrenal chromaffin cells. J. Neurochem. 58:1992;1652-1658.
40. 2 from rat liver mitochondria. Methods Enzymol. 197:1991;365-373.
41. Vibat C.R., Lasalde J.A., McNamee M.G., Ochoa E.L. Differential desensitization properties of rat neuronal nicotinic acetylcholine receptor subunit combinations expressed in Xenopus laevis oocytes. Cell. Mol. Neurobiol. 15:1995;411-425.
42. Volterra A., Trotti D., Cassutti P., Tromba S., Salvaggio A., Melcangi R.C., Racagni G. High sensitivity of glutamate uptake to extracellular free arachidonic acid levels in rat cortical synaptosomes and astrocytes. J. Neurochem. 59:1992;600-606.
43. L. Wilkinson, SYSTAT: The system for statistics, Systat Inc, Evaston, IL, 1990.
44. Zamani M.R., Allen Y.S., Owen L.P., Gray J.A. Nicotine modulates the neurotoxic effect of beta-amyloid (25-35) in hippocampal cultures. Neuroreport. 8:1997;513-517.